Follow the 셀리버리 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 셀리버리 has logged 40 insider filings. The latest transaction was reported on 14 March 2024 (Other). Among the most active insiders: 조대웅. The full history is openly available.
40
Insider Decl.
n/a
Thresholds
n/a
8 ops.
Buy Volume
n/a
3 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.